Phoenix PK/PD Platform Description

Experience seamless collaboration and knowledge sharing across your organization with a comprehensive platform that integrates all essential tools, allowing for secure workflows and the use of Phoenix-based applications alongside third-party software. With more than 6,000 researchers relying on Phoenix WinNonlin for non-compartmental analysis (NCA), toxicokinetic modeling, and pharmacokinetic and pharmacodynamic (PK/PD) modeling, it has become the preferred choice among biopharmaceutical companies, academic institutions, and 11 international regulatory bodies, including the US FDA, EMA, and PMDA. Additionally, the Phoenix Platform offers advanced features like population PK/PD (popPK) modeling through Phoenix NLME and Level A correlation capabilities provided by the Phoenix IVIVC Toolkit, while its Validation Suites enable rapid software validation in less than half an hour, ensuring efficiency and compliance. This powerful suite not only enhances research productivity but also fosters innovation by enabling users to streamline their workflows effectively.

Integrations

No Integrations at this time

Reviews

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Company Details

Company:
Certara
Year Founded:
2008
Headquarters:
United States
Website:
www.certara.com/software/phoenix-pkpd/

Media

Phoenix PK/PD Platform Screenshot 1
Recommended Products
$300 Free Credits to Build on Google Cloud Icon
$300 Free Credits to Build on Google Cloud

New customers can spin up VMs, build with AI, and query data at no cost.

Put your $300 in credit toward real workloads, then keep building with free monthly usage for 20+ products. No commitment and no charge until you upgrade.
Start Free

Product Details

Platforms
Web-Based
Types of Training
Training Docs
Webinars
Training Videos
Customer Support
Business Hours
Online Support

Phoenix PK/PD Platform Features and Options

Phoenix PK/PD Platform User Reviews

Write a Review
  • Previous
  • Next